0002122106-26-000001.txt : 20260323
0002122106-26-000001.hdr.sgml : 20260323
20260323155715
ACCESSION NUMBER: 0002122106-26-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260323
DATE AS OF CHANGE: 20260323
EFFECTIVENESS DATE: 20260323
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: DNP THERAPEUTICS INC
CENTRAL INDEX KEY: 0002122106
ORGANIZATION NAME:
EIN: 413802036
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-577369
FILM NUMBER: 26781990
BUSINESS ADDRESS:
STREET 1: 205 WALDEN STREET APT1S
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (443) 896-3942
MAIL ADDRESS:
STREET 1: 205 WALDEN STREET APT1S
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
D
1
primary_doc.xml
X0708
D
LIVE
0002122106
DNP THERAPEUTICS INC
205 WALDEN STREET APT1S
CAMBRIDGE
MA
MASSACHUSETTS
02140
(443) 896-3942
DELAWARE
None
None
Corporation
true
2026
Randall
Craig
Mazzarino
205 WALDEN STREET APT1S
CAMBRIDGE
MA
MASSACHUSETTS
02140
Executive Officer
Director
Other Technology
Decline to Disclose
- 06b
false
2026-03-05
false
true
true
false
0
1000000
470000
530000
false
7
0
0
0
false
DNP THERAPEUTICS INC
Randall Mazzarino
Randall Mazzarino
CEO
2026-03-23